abstracts

0

Page précédente

Abstracts Lille 2003

Type présentation Jour N° Session N°communication Auteurs Titre Adresses
Poster Mercredi 16/04   15  P168 C Verstuyft (1); M Schwab (2); E Schaeffeler (2); R Kerb (3); U Brinkmann (3); P Jaillon (1); C Funck-Brentano (1); L Becquemont (1); DIGOXIN PHARMACOKINETICS AND MDR1 GENETIC POLYMORPHISMS
Abstract complet
(1) Pharmacologie, Faculté de médecine Saint-Antoine, PARIS; (2) Dr. Margarete Fischer-Bosch-Institut für Klinische Pharmakologie, Robert Bosch foundation, STUTTGART, ALLEMAGNE; (3) Epidauros Biotechnologie, Epidauros Biotechnologie, BERNRIED, ALLEMAGNE;
Poster Mercredi 16/04   15  P169 S Morin (1); MA Loriot (2); HK Thijssen (3); A Robert (4); S Strabach (5); C Verstuyft (1); L Dubert (1); C Funck-Brentano (5); P Jaillon (1); PH Beaune (2); L Becquemont (1); VARIATIONS OF INR AND FACTOR VII ARE LINKED TO CYTOCHROME P450 2C9 GENOTYPE
Abstract complet
(1) Service de Pharmacologie, Faculté de médecine Saint-Antoine, PARIS; (2) INSERM U 490, Université Paris V, PARIS; (3) Service de Pharmacologie, Université de Maastricht, MAASTRICHT, PAYS-BAS; (4) Service d’hémostase, CHU Saint-Antoine, PARIS; (5) Centre d’investigation clinique, CHU Saint-Antoine, PARIS;
Poster Mercredi 16/04   15  P170 T Damy (1); F Pousset (2); H Caplain (3); JS Hulot (1); PH Lechat (1); PHARMACOKINETIC AND PHARMACODYNAMIC INTERACTIONS BETWEEN METOPROLOL AND DRONEDARONE IN HEALTHY SUBJECTS
Abstract complet
(1) Service de Pharmacologie, Hôpital Pitié-Salpétrière, PARIS; (2) Service de Cardiologie, Hôpital Pitié-Salpétrière, PARIS; (3) Aster Clinical Research Center, 3-5 rue Eugène Millon, PARIS;
Poster Mercredi 16/04   15  P171 D Zhang (1); C Ganière-Monteil (2); Y Médard (1); M Bourin (2); E Jacqz-Aigrain (1); PHENOTYPE AND GENOTYPE FOR THIOPURINE METHYLTRANSFERASE ACTIVITY IN THE FRENCH CAUCASIAN POPULATION: IMPACT OF AGE
Abstract complet
(1) Pharmacologie Pédiatrique – Pharmacogénétique, Hôpital Robert Debré, PARIS; (2) Pharmacologie, Hôpital Hôtel-Dieu, NANTES;
Poster Mercredi 16/04   15  P172 M Fakhoury (1); R Serreau (1); Y Medard (1); AL Delezoide (2); E Jacqz-Aigrain (1); REAL TIME QUANTITATIVE RT-PCR OF CYP3A IN PLACENTA
Abstract complet
(1) Pharmacology Unit, Robert Debré Hospital, PARIS; (2) Foetopathology unit, Robert Debré Hospital, PARIS;
Poster Mercredi 16/04   15  P173 JM Poirier (1); O Zouai (1); JL Meynard (2); K Lacombe (2); PM Girard (2); P Jaillon (1); LACK OF EFFECT OF GENDER, AGE, WEIGHT AND BODY MASS INDEX ON TROUGH LOPINAVIR PLASMA CONCENTRATIONS IN HIV-EXPERIENCED PATIENTS TREATED WITH KALETRA
Abstract complet
(1) Department of pharmacology, Saint-Antoine University Hospital, PARIS; (2) Department of Infectious Diseases, Saint-Antoine Hospital, PARIS;
Poster Mercredi 16/04   15  P174 S Laporte (1); B Tranchand (2); A Viallon (3); M Ollagnier (4); M Cucherat (5); C Guy (4); H Décousus (1); P Mismetti (1); POOLING OF INDIVIDUAL TOXICOKINETIC CASE REPORTS USING A POPULATION APPROACH MODEL
Abstract complet
(1) Unité de Pharmacologie Clinique, EA3065, CHU Saint-Etienne Bellevue, SAINT-ETIENNE; (2) Centre Léon Bérard, Rue Laënnec, LYON; (3) Service d’Accueil des Urgences, EA3065, CHU Saint-Etienne Bellevue, SAINT-ETIENNE; (4) Unité de Pharmacologie et Toxicologie, CHU Saint-Etienne Bellevue, SAINT-ETIENNE; (5) EA 643 Faculté RTH Laennec, Service de Biostatistiques, CHU Lyon, LYON;
Poster Mercredi 16/04   15  P175 F Stanke-Labesque (1); S Larrat (1); G Bessard (1); JP Zarski (2); C Souvignet (2); RIBAVIRIN QUANTIFICATION FOR THERAPEUTIC DRUG MONITORING DURING CHRONIC HEPATITIS C COMBINATION TREATMENT
Abstract complet
(1) Laboratoire de Pharmacologie, CHU Grenoble, GRENOBLE; (2) Département d’hépato-gastroentérologie, CHU Grenoble, GRENOBLE;
Poster Mercredi 16/04   15  P176 N Simon (1); G Slepchenko (2); O Pérus (2); JC Levron (3); M Raucoules-Aimé (2); B Bruguerolle (1); POPULATION PHARMACOKINETICS OF SUFENTANIL IN OBESE PATIENTS
Abstract complet
(1) Laboratoire de Pharmacologie médicale et clinique, Faculté de médecine, MARSEILLE; (2) Département d’anesthésie-réanimation, Hôpital l’Archet 2, NICE; (3) Laboratoire Janssen Cilag, Janssen Research Fondation, VAL DE REUIL;
Poster Mercredi 16/04   15  P177 N Simon (1); F Lacroix (2); E Deturmeny (1); O Paut (2); J Camboulives (2); B Bruguerolle (1); COMPARATIVE PHARMACOKINETICS OF 0.2 VS 0.375 % ROPIVACAINE DURING FASCIA ILIACA COMPARTMENT BLOCK IN CHILDREN
Abstract complet
(1) Laboratoire Pharmacologie médicale et clinique, Faculté de médecine, MARSEILLE; (2) Departement d’anesthésie Réanimation Pédiatrique, CHU Timone, MARSEILLE;
Poster Mercredi 16/04   15  P178 P Nony (1); JP Boissel (1); PREDICTING DRUG FORGIVENESS: A STANDARDISED GRAPHICAL APPROACH
Abstract complet
(1) EA 643, Hôpital Cardiologique, LYON;
Poster Mercredi 16/04   15  P179 E Dailly (1); M Pannier (2); P Jolliet (1); M Bourin (1); POPULATION PHARMACOKINETICS OF CEFTAZIDIME IN BURN PATIENTS
Abstract complet
(1) Laboratoire de Pharmacologie, Hôtel Dieu, NANTES; (2) Service des Brûlés, Hôtel Dieu, NANTES;
Poster Mercredi 16/04   15  P180 S Payen (1); R Serreau (2); A Munck (3); Y Aujard (4); Y Aigrain (5); F Bressolle (1); E Jacqz-Aigrain (2); POPULATION PHARMACOKINETICS OF CIPROFLOXACIN IN PEDIATRIC AND ADOLESCENT PATIENTS WITH ACUTE INFECTIONS
Abstract complet
(1) Clinical Pharmacokinetic Laboratory, Faculty of Pharmacy, MONTPELLIER; (2) Paediatric Pharmacology and Pharmacogenetics, Robert Debré Hospital, PARIS; (3) Gastro-Enterology, Robert Debré Hospital, PARIS; (4) Neonatologie, Robert Debré Hospital, PARIS; (5) Paediatric Surgery, Robert Debré Hospital, PARIS;
Poster Mercredi 16/04   15  P181 C Verstuyft (1); F Marcellin (2); L Morand-Joubert (3); O Launay (4); G Peytavin (5); L Gerard (2); L Becquemont (6); JP Aboulker (2); For The Anrs 081 (7); IMPACT OF MDR1 (C3435T) GENETIC POLYMORPHISM IN PATIENTS NAÏVE TREATED WITH HAART INCLUDING INDINAVIR (IDV)
Abstract complet
(1) Pharmacology Department, Faculty of medecine, PARIS; (2) SC 10, Villejuif, VILLEJUIF; (3) Virology Department, Saint-Antoine Hospital, PARIS; (4) Infectious Disease Department, Bichat-Claude Bernard, PARIS; (5) Pharmacy Department, Bichat-Claude Bernard, PARIS; (6) Pharmacology Department, Saint-Antoine Hospital, PARIS; (7) ANRS, PARIS;
Poster Mercredi 16/04   15  P182 X Zhang (1); V Favier (2); JM Lang (3); J Reynes (4); D Rey (3); R Rouzier-Panis (5); M Gerber (2); E Gaudeul-Ehrhart (2); P Desche (2); I Patel (1); PHARMACOKINETICS OF HIV FUSION INHIBITOR T-20 (FUZEON) AFTER BOTH INTRAVENOUS (IV) AND SUBCUTANEOUS (SC) ADMINISTRATION TO HIV-1 INFECTED PATIENTS
Abstract complet
(1) Clinical pharmacology dpt, Hoffmann-La ROCHE Inc., NUTLEY, USA; (2) Institut de Pharmacologie Clinique ROCHE, Hôpital Civil de Strasbourg, STRASBOURG; (3) Antenne d’Immuno-Onco-Hematologie, Hôpital Civil de Strasbourg, STRASBOURG; (4) Service des Maladies Infectueuses et Tropicales, Hôpital Gui de Chauliac, MONTPELLIER; (5) Centre CAP, Clinique Rech, MONTPELLIER;
Poster Mercredi 16/04   15  P183 E Caudron (1); V Jullien (1); C Amrein (2); R Guillemain (2); P Chevallier (2); C Le Beller (1); A Lillo-Le Louet (1); EM Billaud (1); TACROLIMUS THERAPEUTIC DRUG MONITORING (TDM) IN THE MANAGEMENT OF DRUG INTERACTION WITH VORICONAZOLE IN PULMONARY TRANSPLANTATION
Abstract complet
(1) Pharmacologie Toxicologie, HEGP, PARIS; (2) Chirurgie Cardio Vasculaire, HEGP, PARIS;
Poster Mercredi 16/04   15  P184 O Tribut (1); C Camus (2); C Arvieux (3); H Allain (1); D Bentué-Ferrer (1); TACROLIMUS AND PROTEASE INHIBITORS INTERACTION IN PATIENTS WITH LIVER TRANSPLANTATION
Abstract complet
(1) Laboratoire de Pharmacologie Expérimentale et Clinique, Faculté de Médecine, RENNES; (2) Service de Réanimation Médicale, Hôpital Pontchaillou, RENNES; (3) Service des Maladies Infectieuses, Hôpital Pontchaillou, RENNES;
Poster Mercredi 16/04   15  P185 N Ferrari (1); S Brique (1); P Odou (2); L Kroumova (1); C Lamotte (1); J Wiart (3); P Devos (4); M Lhermitte (3); C Libersa (1); NIFEDIPINE AND GRAPEFRUIT JUICE: FACT OR FICTION ?
Abstract complet
(1) CIC Lille, CHRU LILLE, LILLE; (2) Département de biopharmacie et de pharmacie clinique, Faculté de Pharmacie, LILLE; (3) Laboratoire de biochimie et de biologie moléculaire, CHRU LILLE, LILLE; (4) D.I.M., CHRU LILLE, LILLE;
Poster Mercredi 16/04   15  P186 B Guillet (1); B Bordas (1); R Purgus (2); B Dussol (2); A Durand (1); Y Berland (2); P Pisano (1); PHARMACOKINETICS OF MYCOPHÉNOLIC ACID (MPA) TOTAL AND FREE IN RENAL TRANSPLANT PATIENTS WITH CHRONIC GRAFT DYSFUNCTION
Abstract complet
(1) Fédération de Pharmacologie, CHU Timone, 254 rue St Pierre, MARSEILLE; (2) Service de Néphrologie, CHU Conception, 170 bd Baille, MARSEILLE;
Poster Mercredi 16/04   15  P187 Y Hijazi (1); R Boulieu (2); CONTRIBUTION OF CYP3A4, CYP2B6, AND CYP2C9 ISOFORMS TO N-DEMETHYLATION OF KETAMINE IN HUMAN LIVER MICROSOMES
Abstract complet
(1) PDMP, Hoffmann-La Roche, BASEL, SWITZERLAND; (2) Laboratoire de Pharmacocinétique Clinique, Université de Lyon 1, LYON;

Page précédente